Procept biorobotics stock.

Jan 9, 2023 · On January 9, 2023, PROCEPT BioRobotics Corporation (the "Company") issued a press release announcing its preliminary revenue results for the quarter and fiscal year ended December 31, 2022. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Procept biorobotics stock. Things To Know About Procept biorobotics stock.

PROCEPT BioRobotics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 28, 2023REDWOOD CITY, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation ...Aug 1, 2023 · REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care ... REDWOOD CITY, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter endedSAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third... 12 Oct '23.

PROCEPT BioRobotics is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. We develop, …PROCEPT BioRobotics is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. We develop, …Find real-time PRCT - PROCEPT BioRobotics Corp stock quotes, company profile, news and forecasts from CNN Business. ... PROCEPT BioRobotics Corp (NASDAQ:PRCT) 36.97. Delayed Data. As of Nov 29

Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently down 6.05% so far this month. During the month of May, Procept Biorobotics Corp’s stock price has reached a high of $31.82 and a low of $27.90. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as …

REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...See Insiders’ Hot Stocks on TipRanks >> PROCEPT BioRobotics (PRCT) ... Currently, the analyst consensus on PROCEPT BioRobotics is a Strong Buy with an average price target of $48.75, a 46.8% ...Apr 11, 2023 · Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 24.96% so far this month. During the month of April, Procept Biorobotics Corp’s stock price has reached a high of $35.90 and a low of $28.80. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $25.90. Year ... May 31, 2023 · Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 10.07% so far this month. During the month of May, Procept Biorobotics Corp’s stock price has reached a high of $34.48 and a low of $26.66. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $25.29. Year to ...

Complete PROCEPT BioRobotics Corp. stock information by Barron's. View real-time PRCT stock price and news, along with industry-best analysis.

PROCEPT BioRobotics develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial ...

PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance Provided by GlobeNewswire. Nov 1, 2023 8:02 PM UTC ... Stock-based compensation expense ...In addition, PROCEPT BioRobotics has granted the underwriters a 30-day option to purchase up to an additional 663,325 shares of its common stock at the public offering price, less underwriting ...PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance Provided by GlobeNewswire. Nov 1, 2023 8:02 PM UTC ... Stock-based compensation expense ...Procept BioRobotics ( NASDAQ: PRCT) is off 8% in Wednesday morning trading after rival Intuitive Surgical ( NASDAQ: ISRG) announced after the bell Tuesday it received US FDA 510 (k) clearance for ...PROCEPT BioRobotics Corporation (PRCT) Stock Historical Prices & Data - Yahoo Finance S&P 500 (+0.10%) Dow 30 -40.33(-0.12%) Nasdaq +10.56(+0.08%) Russell 2000 -19.08(-1.10%) Crude Oil...PROCEPT BioRobotics will host a conference call to discuss the second quarter 2022 financial results after the market close on Thursday, August 4th, 2022, at 1:30 p.m. Pacific Time / 4:30 p.m ...REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...

Contact Email [email protected]. Phone Number 650-232-7200. PROCEPT is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in ...Nov 1, 2023 · PROCEPT BioRobotics Corporation RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (Unaudited, in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022: Net loss $ (24,622) $ (22,613) $ (78,393) $ (58,982) Depreciation and amortization expense 1,054 703 2,489 2,178 Stock-based compensation expense 5,326 ... PROCEPT BioRobotics, a surgical robotics company developing intelligent solutions to transform the field of urology, has included HydroCision technology as part of Aquablation therapy ®, the ...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.On January 9, 2023, PROCEPT BioRobotics Corporation (the "Company") issued a press release announcing its preliminary revenue results for the quarter and fiscal year ended December 31, 2022. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.PROCEPT BioRobotics Corporation Common Stock (PRCT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.PROCEPT BioRobotics Corporation has completed an IPO in the amount of $163.9 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 6,556,000

Disclaimer. Procept Biorobotics Corporation published this content on 01 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 November 2023 22:40:05 UTC.

PROCEPT BioRobotics also expects to grant the underwriters a 30-day option to purchase up to an additional $18,750,000 of shares of its common stock. The …SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Procept BioRobotics Main Entrance. SAN JOSE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on developing transformative solutions in urology, proudly announces the grand opening of its state-of-the-art global corporate headquarters in ...PROCEPT BioRobotics Corporation (PRCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. ... The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on …Full Year 2022 Financial Results. Revenue for the full year 2022 was $75.0 million, compared to $34.5 million for the full year 2021. The growth was primarily driven by increases in U.S. revenues, attributable to system placements and increased utilization. Gross margin for full year 2022 was 49%, compared to 46% for the full year 2021.PROCEPT BioRobotics Corporation is a surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with …Contact Email [email protected]. Phone Number 650-232-7200. PROCEPT is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in ...

SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third... 12 Oct '23.

REDWOOD CITY, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing ...

SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023.Analysis of Insider Buy/Sell and Relationship with Stock Price. On November 13, 2023, Morgan Wood sold 25,000 shares of PROCEPT BioRobotics Corp at a price of $32.19 per share. This transaction reduced Wood's holdings in the company and is part of a broader pattern of insider selling at PRCT. Over the past year, Wood has sold a total of …Nov 15, 2023 · Analysis of Insider Buy/Sell and Relationship with Stock Price. On November 13, 2023, Morgan Wood sold 25,000 shares of PROCEPT BioRobotics Corp at a price of $32.19 per share. This transaction ... PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City. Nov 13, 2023 (marketscreener.com) SAN JOSE, Calif., Nov. 13, 2023 -- PROCEPT BioRobotics® , a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, …About PROCEPT BioRobotics Stock. PROCEPT BioRobotics is a clinical-stage medical device company based in Silicon Valley. The Company has developed a disruptive surgical product for transurethral resection of prostate tissue – The AquaBeam® – and other treatment and diagnostic applications. The AquaBeam is a personalized image-guided tissue ...You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.Disclaimer. Procept Biorobotics Corporation published this content on 01 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 November 2023 22:40:05 UTC.Nov 30, 2023 · PROCEPT BioRobotics has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500. SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ:PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing ...According to the issued ratings of 6 analysts in the last year, the consensus rating for PROCEPT BioRobotics stock is Buy based on the current 6 buy ratings for PRCT. The average twelve-month price prediction for PROCEPT BioRobotics is $43.00 with a high price target of $49.00 and a low price target of $37.00.PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ...

REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader... Menu icon A vertical stack of three evenly ...May 31, 2023 · Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 10.07% so far this month. During the month of May, Procept Biorobotics Corp’s stock price has reached a high of $34.48 and a low of $26.66. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $25.29. Year to ... 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement PROCEPT BioRobotics Corporation (PRCT) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 37.36 +0.29 (+0.78%) At...Instagram:https://instagram. nasdaq predictionsbest stocks under 50 centsbest financial advisors in washington statepurchase bitcoins with venmo View PROCEPT BioRobotics Corporation PRCT investment & stock information. Get the latest PROCEPT BioRobotics Corporation PRCT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. otc stock brokermortgage companies in new jersey PROCEPT BioRobotics has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500. corning glass ticker Aug 2, 2023 · In addition, PROCEPT BioRobotics has granted the underwriters a 30-day option to purchase up to an additional 663,325 shares of its common stock at the public offering price, less underwriting ... The latest price target for PROCEPT BioRobotics ( NASDAQ: PRCT) was reported by Leerink Partners on Monday, October 16, 2023. The analyst firm set a price target for 37.00 expecting PRCT to rise ...REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader... Menu icon A vertical stack of three evenly ...